- From: Eric Prud'hommeaux <eric@w3.org>
- Date: Mon, 13 Jan 2014 15:44:30 -0500
- To: public-semweb-lifesci@w3.org, Charlie Mead <charlie.mead@yahoo.com>, Claude Nanjo <cnanjo@gmail.com>, Josh Mandel <jmandel@gmail.com>, Hans Constandt <hans@ontoforce.com>, Christel Daniel <christel.daniel@crc.jussieu.fr>, 'Sajjad Hussain' <sajjad.hussain@crc.jussieu.fr>, Mustafa Yuksel <mustafa@srdc.com.tr>, Gokce Banu Laleci Erturkmen <gokce@srdc.com.tr>, Erick Von Schweber <erick@surveyorhealth.com>, "Solbrig, Harold R." <Solbrig.Harold@mayo.edu>, Stan Huff <Stan.Huff@imail.org>, "Jiang, Guoqian, M.D., Ph.D." <Jiang.Guoqian@mayo.edu>, "Emory Fry (Google Drive)" <eafry@gmx.com>, Conor Dowling <conor-dowling@caregraf.com>, David Booth <david@dbooth.org>, Arash Shaban-Nejad <arash.shaban-nejad@mail.mcgill.ca>, Michael Denny <msdenny@mitre.org>, Kerstin Forsberg <kerstin.l.forsberg@gmail.com>, hong.sun@agfa.com, jakub.kozak@collite.cz, suat@srdc.com.tr, a.j.g.gray@hw.ac.uk, Frank.van.Harmelen@cs.vu.nl, annette@cs.vu.nl
Agenda:
FDA Therapeutic Area strawman.
<http://www.w3.org/2013/12/FDA-TA/>
Trial interoperability:
What's a reallistic next step?
What's a reallistic overall objective?
Disease ontology (Emory, Neda, Claude)?
Please RSVP so I can get a head count for the bridge reservation.
Call will be from 16:00-17:00 UTC (08 PDT, 11 EDT, 17 CET)
using the Zakim Bridge: +1.617.761.6200, with
Conference Code: 4257 ("HCLS")
For text, we will use the IRC channel #hcls on irc.w3.org port 6665.
Please try out <http://irc.w3.org/> if you don't have an IRC client.
--
-ericP
office: +1.617.599.3509
mobile: +33.6.80.80.35.59
(eric@w3.org)
Feel free to forward this message to any list for any purpose other than
email address distribution.
There are subtle nuances encoded in font variation and clever layout
which can only be seen by printing this message on high-clay paper.
Received on Monday, 13 January 2014 20:45:03 UTC